Clinical Trial: The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency
Study Status: Completed
Recruit Status: RECRUITING
Condition: Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency
Study Type: INTERVENTIONAL
Official Title: The ENERGY Study: An Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INZ-701 in Infant Subjects With Ectonucleotide Pyrophosphatase/ Phosphodieste
Brief Summary:
The primary purpose of Study INZ701-104 (the ENERGY study) is to assess the safety and tolerability of INZ-701 in infants with ENPP1 Deficiency.
Read more